KATHERINE KERSEY: Open Payments
NPI 1033519996 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 45 payments from 21 companies in 2025. Trend: 2023 $1,073 · 2024 $840 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $175 |
| Novartis Pharmaceuticals Corporation | 5 | $112 |
| Olympus America Inc. | 4 | $89 |
| Antares Pharma, Inc. | 4 | $87 |
| ConvaTec Inc. | 2 | $55 |
| COLOPLAST CORP | 2 | $46 |
| UROGEN PHARMA, INC. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $35 |
| Boston Scientific Corporation | 2 | $35 |
| Astellas Pharma US Inc | 2 | $32 |
Products named: GEMTESA, PLUVICTO, iTIND System, XYOSTED, XTANDI, ORGOVYX, ERLEADA, Axonics.
Industry payments across KY — which companies pay providers there.
